SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A0B5F70728DF07209F1E36076D65961A93B32320FDC332A435ACE5CA6A069F0DD5DBE4510806304E6CB7CC62C9B3293F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A0B5F70728DF07209F1E36076D65961A93B32320FDC332A435ACE5CA6A069F0DD5DBE4510806304E6CB7CC62C9B3293F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A0B5F70728DF07209F1E36076D65961A93B32320FDC332A435ACE5CA6A069F0DD5DBE4510806304E6CB7CC62C9B3293F
http://www.w3.org/2000/01/rdf-schema#comment
"LY6E overexpression is associated with Breast Cancer Progression Immune Escape and Drug Resistance."
xsd:string
http://purl.uniprot.org/uniprot/#_A26852EAD998D1ED59F8DE9BAE07FA06B2AADCF8609E749D1FF5D8103E36CF6CC638A5DF0416D017CF6458BC975A20B3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A0B5F70728DF07209F1E36076D65961A93B32320FDC332A435ACE5CA6A069F0DD5DBE4510806304E6CB7CC62C9B3293F
http://purl.uniprot.org/uniprot/Q16553
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A0B5F70728DF07209F1E36076D65961A93B32320FDC332A435ACE5CA6A069F0DD5DBE4510806304E6CB7CC62C9B3293F
http://purl.uniprot.org/uniprot/#_Q16553-mappedCitation-27197181
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A0B5F70728DF07209F1E36076D65961A93B32320FDC332A435ACE5CA6A069F0DD5DBE4510806304E6CB7CC62C9B3293F